HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone-releasing hormone agonist.

Abstract
The effects of leuprorelin acetate, a luteinizing hormone-releasing hormone agonist (LHRH-A), on prostate carcinogenesis in probasin/SV40 Tag transgenic rat was investigated. Fifteen weeks after administration of 0.28 and 2.8 mg/kg leuprorelin, prostate weights and serum testosterone levels were significantly decreased compared to values for transgenic controls. Histopathological findings revealed that the incidence of prostatic adenocarcinomas was significantly reduced in ventral, dorsal and lateral lobes of the prostate, correlating with decreased expression of SV40 Tag oncoprotein as well as inhibition of DNA synthesis and proliferation of epithelial cells in neoplastic lesions of the ventral prostate. Microarray analysis further showed leuprorelin acetate to significantly inhibit testicular steroidogenesis, suppressing the expression of SV40 Tag oncoprotein and altering the expression of a large number of genes which might be involved in the inhibition of prostate cancer progression in this rat model.
AuthorsMahmoud M Said, Naomi Hokaiwado, Mingxi Tang, Kumiko Ogawa, Shugo Suzuki, Hala M Ghanem, Amr Y Esmat, Makoto Asamoto, Fawzia M Refaie, Tomoyuki Shirai
JournalCancer science (Cancer Sci) Vol. 97 Issue 6 Pg. 459-67 (Jun 2006) ISSN: 1347-9032 [Print] England
PMID16734723 (Publication Type: Journal Article)
Chemical References
  • Androgen-Binding Protein
  • Antigens, Polyomavirus Transforming
  • Antineoplastic Agents, Hormonal
  • RNA, Messenger
  • Receptors, Androgen
  • probasin
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Leuprolide
Topics
  • Adenocarcinoma (drug therapy, genetics)
  • Androgen-Binding Protein (genetics)
  • Animals
  • Animals, Genetically Modified
  • Antigens, Polyomavirus Transforming (genetics)
  • Antineoplastic Agents, Hormonal (pharmacology)
  • Follicle Stimulating Hormone (blood)
  • Gonadotropin-Releasing Hormone (agonists)
  • Immunohistochemistry
  • Leuprolide (pharmacology)
  • Luteinizing Hormone (blood, drug effects)
  • Male
  • Oligonucleotide Array Sequence Analysis
  • Prostate (drug effects)
  • Prostatic Neoplasms (drug therapy, genetics)
  • RNA, Messenger (analysis)
  • Rats
  • Receptors, Androgen (drug effects, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Seminal Vesicles (drug effects)
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: